Have a personal or library account? Click to login
Correlations Between Clinical Parameters and Health-Related Quality of Life in Postmenopausal Osteoporotic Women Cover

Correlations Between Clinical Parameters and Health-Related Quality of Life in Postmenopausal Osteoporotic Women

Open Access
|Dec 2016

References

  1. 1. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster Y. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2013; 24(1): 23-57.10.1007/s00198-012-2074-y
  2. 2. Ström O, Borgström F, Kanis JA, Compsto, J, Cooper C, McCloskey EV, et al. Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 2011; 6(1): 59-155.10.1007/s11657-011-0060-1
  3. 3. Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O’Malley CD. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 2014; 9(1): 1-10.10.1007/s11657-014-0182-3
  4. 4. Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011; 377(9773): 1276-87.10.1016/S0140-6736(10)62349-5
  5. 5. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359(9321): 1929-36.10.1016/S0140-6736(02)08761-5
  6. 6. Gong B, Mandair GS, Wehrli FW, Morris MD. Novel assessment tools for osteoporosis diagnosis and treatment. Curr Osteoporos Rep 2014; 1-9.10.1007/s11914-014-0215-2621893724879507
  7. 7. Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX® and its applications to clinical practice. Bone 2009; 44(5): 734-43.10.1016/j.bone.2009.01.37319195497
  8. 8. Unnanuntana A, Gladnick BP, Donnelly E, Lane JM. The assessment of fracture risk. J Bone Joint Surg Am 2010; 92(3): 743-53.10.2106/JBJS.I.00919282782320194335
  9. 9. Wilson S, Sharp CA, Davie MWJ. Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review. Osteoporos Int 2012; 23(12): 2749-68.10.1007/s00198-012-2050-622814944
  10. 10. Romagnoli E, Carnevale V, Nofroni I, D’Erasmo E, Paglia F, De Geronimo S, et al. Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical vertebral fractures. Osteoporos Int 2004; 15(12): 975-80.10.1007/s00198-004-1633-215118812
  11. 11. Lips P, Leplege A. Development and validation of a quality of life questionnaire for patients with vertebral fractures: Qualeffo-41. Qual Life Res 2000; 9(1): 763-6.10.1023/A:1008982124694
  12. 12. Lips P, van Schoor NM. Quality of life in patients with osteoporosis. Osteoporos Int 2005; 16(5): 447-55.10.1007/s00198-004-1762-715609073
  13. 13. Bianchi ML, Orsini MR, Saraifoger S, Ortolani S, Radaelli G, Betti S. Quality of life in post-menopausal osteoporosis. Health Qual Life Outcomes 2005; 3(1): 78.10.1186/1477-7525-3-78132527316321148
  14. 14. Cohen A, Liu XS, Stein EM, McMahon DJ, Rogers HF, LeMaster J, et al. Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2009; 94(11): 4351-60.10.1210/jc.2009-0996277566119837923
  15. 15. Cvijetic S, Mestrovic T, Crkvenac A, Davila S, Korsic M. Quality of life in osteoporotic patients with hip fracture and without fracture. Arh Hig Rada Toksikol 2002; 53(4): 257-62.
  16. 16. Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di Matteo L, Scendoni P, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 2007; 34(7): 1551-60.
  17. 17. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011; 25(4): 585-91.10.1016/j.beem.2011.05.00221872800
  18. 18. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22(4): 477-501.10.1210/edrv.22.4.043711493580
  19. 19. Basaran S, Guzel R, Coskun-Benlidayi I, Guler-Uysal F. Vitamin D status: effects on quality of life in osteoporosis among Turkish women. Qual Life Res 2007; 16(9): 1491-9.10.1007/s11136-007-9257-617828579
  20. 20. Mata-Granados JM, Cuenca-Acevedo JR, de Castro ML, Holick MF, Quesada-Gómez JM. Vitamin D insufficiency together with high serum levels of vitamin A increases the risk for osteoporosis in postmenopausal women. Arch Osteoporos 2013; 8(1-2): 1-8.10.1007/s11657-013-0124-523417776
  21. 21. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357(3): 266-81. 10.1056/NEJMra07055317634462
  22. 22. Rizzoli R, Boonen S, Brandi ML, Bruyère O, Cooper C, Kanis JA, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin 2013; 29(4): 305-13.10.1185/03007995.2013.76616223320612
  23. 23. Reginster JY. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr Med Res Opin 2005; 21(4): 579-85.10.1185/030079905X41435
  24. 24. Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev 2012; 33(3): 456-92.10.1210/er.2012-1000
  25. 25. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84(1): 18-28.10.1093/ajcn/84.1.18
  26. 26. Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002; 75(4): 611-5.10.1093/ajcn/75.4.611
  27. 27. Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Aspects Med 2005; 26(3): 203-19.10.1016/j.mam.2005.01.005
  28. 28. Ohta H, Uemura Y, Nakamura T, Fukunaga M, Ohashi Y, Hosoi T, et al. Serum 25-hydroxyvitamin D level as an independent determinant of quality of life in osteoporosis with a high risk for fracture. Clinl Ther 2014; 36(2): 225-35.10.1016/j.clinthera.2013.12.007
  29. 29. Tadic I, Vujasinovic Stupar N, Tasic L, Stevanovic D, Dimic A, Stamenkovic B, et al. Validation of the osteoporosis quality of life questionnaire QUALEFFO-41 for the Serbian population. Health Qual Life Outcomes 2012; 18(10): 1.10.1186/1477-7525-10-74
  30. 30. http://www.shef.ac.uk/FRAX. Accessed 20 May 2014.
  31. 31. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pain and disability associated with new vertebral fractures and other spinal conditions. J Clin Epidemiol1994; 47(3): 231-9.10.1016/0895-4356(94)90004-3
  32. 32. Ross PD. Clinical consequences of vertebral fractures. Am J Med 1997; 103(2): S30-43.10.1016/S0002-9343(97)90025-5
  33. 33. Lips P, Cooper C, Agnusdei DF, Caulin F, Egger P, Johnell O, et al. Quality of life in patients with vertebral fractures: validation of the quality of life questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Osteoporos Int 1999; 10(2): 150-60.10.1007/s00198005021010501796
  34. 34. Adachi JD, Ioannidis G, Olszynski WP, Brown JP, Hanley DA, Sebaldt RJ, et al. The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord 2002; 3: 1110.1186/1471-2474-3-11
  35. 35. Randell AG, Nguyen TV, Bhalerao N, Silverman SL, Sambrook PN, Eisman JA. Deterioration in quality of life following hip fracture: a prospective study. Osteoporos Int 2000; 11: 460-610.1007/s001980070115
  36. 36. Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, et al. Health−related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. Journal of bone and mineral research 2000; 15(7): 1384-92. 10.1359/jbmr.2000.15.7.1384
  37. 37. Silverman SL, Minshall ME, Shen W, Harper KD, Xie S. The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 2001; 44: 2611-9.10.1002/1529-0131(200111)44:11<;2611::AID-ART441>3.0.CO;2-N
  38. 38. Rostom S, Allali F, Bennani L, Abouqal R, Hajjaj-Hassouni N. The prevalence of vertebral fractures and health-related quality of life in postmenopausal women. Rheumatol Int 2012; 32(4): 971-80.10.1007/s00296-010-1734-5
  39. 39. Guillemin F, Martinez L, Calvert M, Cooper C, Ganiats T, Gitlin M, et al. Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study. Osteoporos Int 2013; 24(12): 3001-10.10.1007/s00198-013-2408-4
  40. 40. de Oliveira Ferreira N, Arthuso M, da Silva R, Pedro AO, Neto AMP, Costa-Paiva L. Quality of life in women with postmenopausal osteoporosis: correlation between QUALEFFO 41 and SF-36. Maturitas 2009; 62(1): 85-90.10.1016/j.maturitas.2008.10.012
  41. 41. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312(7041): 1254-9.10.1136/bmj.312.7041.1254
  42. 42. Yu W, Glüer CC, Fuerst T, Grampp S, Li J, Lu Y, et al. Influence of degenerative joint disease on spinal bone mineral measurements in postmenopausal women. Calcif Tissue Int 1995; 57(3): 169-74.10.1007/BF00310253
  43. 43. Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS. Vitamin D inadequacy among postmenopausal women: a systematic review. QJM 2005; 98(9): 667-76. 10.1093/qjmed/hci096
  44. 44. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011; 22(3): 859-71.
  45. 45. Muir SW, Montero-Odasso M. Effect of Vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2011; 59(12): 2291-300.10.1111/j.1532-5415.2011.03733.x22188076
  46. 46. Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A. Serum levels of 25-hydroxyvitamin D and functional recovery after hip fracture. Arch Phys Med Rehabil 2005; 86(1): 64-8.10.1016/j.apmr.2004.02.01315640991
  47. 47. Di Monaco M, Vallero F, Di Monaco R, Tappero R, Cavanna A. 25-hydroxyvitamin D, parathyroid hormone, and functional recovery after hip fracture in elderly patients. J Bone Miner Metab 2006; 24(1): 42-7.10.1007/s00774-005-0644-116369897
  48. 48. Savic LJ, Savic D. Serum calcium and phosphorus concentration and alkaline phosphatase activity in healthy children during growth and development. Med Preg1 2008; LXI (7-8): 393-9.10.2298/MPNS0808393S
  49. 49. Prado WA. Involvement of calcium in pain and antinociception. Braz J Med Biol Res 200; 34(4): 449-61.10.1590/S0100-879X2001000400003
  50. 50. Schram MT, Trompet S, Kamper AM, de Craen AJ, Hofman A, Euser SM, et al. Serum calcium and cognitive function in old age. J Am Geriatr Soc 2007; 55(11): 1786-92.10.1111/j.1532-5415.2007.01418.x17979900
  51. 51. Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. J Transl Med 2013;11:201.10.1186/1479-5876-11-201376590923984630
  52. 52. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000; 11(1): 76-82. 10.1007/s00198005000910663362
DOI: https://doi.org/10.1515/sjecr-2016-0044 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 333 - 342
Submitted on: Mar 3, 2016
Accepted on: Apr 7, 2016
Published on: Dec 13, 2016
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Vesna Grbovic, Aleksandra Jurisic Skevin, Katarina Parezanovic Ilic, Aleksandra Lucic Tomic, Jasmin Nurkovic, Dejan Jeremic, Dusica Djordjevic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.